Streetbeat News

Stock Prices

BTCUSD

MSTR

Equity research firm Canaccord Genuity has set a share price target of $554 for MicroStrategy Incorporated (NASDAQ:MSTR), citing the company's successful adoption of Bitcoin as its primary treasury reserve asset. The firm's valuation methodology includes a 30% premium to MicroStrategy's software business and a 20% premium to its current Bitcoin reserves. MicroStrategy's shares have surged by 242% since August 2020, and the company added 6,067 Bitcoin to its holdings in Q3, bringing its total to 158,245 Bitcoin.

Portfolio Pulse from Murtuza Merchant

November 02, 2023 | 2:17 pm

AAPL

Apple Inc. is expected to release its Q4 financial results on Nov. 2, 2023. Analysts predict earnings of $1.39 per share, up from $1.29 per share a year ago, and revenue of $89.28 billion, down from $90.15 billion. Apple has reportedly stopped efforts to make its Apple Watch and Health app compatible with Android devices. The company's shares gained 1.9% to close at $173.97 on Wednesday. Several analysts have provided their ratings and price targets for Apple.

Portfolio Pulse from Lisa Levin

November 02, 2023 | 2:16 pm

CFLT

LMND

OTLK

PBLA

RCKY

RELY

US stocks traded higher with the Dow Jones index gaining more than 250 points and NASDAQ rising 1.22%. Real estate shares jumped by 2.2%. Initial jobless claims increased by 5,000 to 217,000. Panbela Therapeutics, Rocky Brands, and Lemonade saw their shares rise by 44%, 41%, and 36% respectively. Outlook Therapeutics, Confluent, and Remitly Global saw their shares drop by 45%, 44%, and 29% respectively.

Portfolio Pulse from Lisa Levin

November 02, 2023 | 2:13 pm

EIS

SPY

USO

A top Israeli general has signaled a willingness to allow fuel to enter Gaza if hospitals run out, according to Reuters. The news may impact the stocks of EIS (iShares MSCI Israel ETF), SPY (SPDR S&P 500 ETF Trust), and USO (United States Oil Fund).

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 2:12 pm

LLY

Eli Lilly reported Q3 sales of $9.49 billion, up 37% Y/Y, beating the consensus of $8.95 billion. The growth was driven by Mounjaro, Verzenio, and Jardiance, as well as $1.42 billion from the sale of rights for the olanzapine portfolio. However, the company cut its annual profit guidance due to recent acquisitions. Eli Lilly's shares are up 4.83% at $581.03.

Portfolio Pulse from Vandana Singh

November 02, 2023 | 2:03 pm

LSXMK

Liberty SiriusXM Gr (NASDAQ:LSXMK) is set to release its quarterly earnings report on November 3, 2023. Analysts estimate an EPS of $0.88. The company's past performance shows a mixed trend with the last quarter missing EPS by $0.91, resulting in a 0.0% drop in share price. The stock is currently trading at $25.12, down 20.47% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 2:02 pm

LSXMA

Liberty SiriusXM Gr (NASDAQ:LSXMA) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $0.85. The company's past performance shows a mixed trend with the last quarter missing EPS by $0.91, resulting in a 0.0% drop in share price. The stock is currently trading at $24.99, down 16.75% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 2:02 pm

CHD

Church & Dwight Co (NYSE:CHD) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an EPS of $0.68. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $90.27 and has seen a 27.13% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 2:01 pm

BABA

A large bullish position has been taken on Alibaba Gr Holding (NYSE:BABA), as noticed by Benzinga's options scanner. The overall sentiment of these big-money traders is split between 54% bullish and 45% bearish. Whales have been targeting a price range from $80.0 to $200.0 for Alibaba over the last 3 months. The price of BABA is up 1.25% at $83.51. Benchmark, UBS, Barclays, and Truist Securities have all given a buy rating with price targets ranging from $126 to $180.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 2:01 pm

BATS:CBOE

Cboe Global Markets (BATS:CBOE) is set to release its quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $1.86. The company's past performance shows a pattern of beating EPS estimates. The stock was trading at $165.68 as of November 1, with a 28.29% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

November 02, 2023 | 2:01 pm